Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 338
Gene Symbol: APOB
APOB
0.020 GeneticVariation disease BEFREE Various studies have shown a relationship between APOB gene polymorphisms and lipoprotein levels, but only few investigated a potential association between APOB polymorphism and GSD, giving contrary results. 17350490 2007
Entrez Id: 5836
Gene Symbol: PYGL
PYGL
0.010 GeneticVariation disease BEFREE We have characterized eight patients from seven families with GSD type VI and identified 11 novel PYGL gene defects. 17705025 2007
Entrez Id: 2542
Gene Symbol: SLC37A4
SLC37A4
0.040 AlteredExpression disease BEFREE Glycogen storage disease (GSD) type Ib is caused by the deficiency of glucose-6-phosphate translocase activity. 19579760 2009
Entrez Id: 64241
Gene Symbol: ABCG8
ABCG8
0.020 GeneticVariation disease BEFREE The aim of this study was to analyze the relationship between D19H and T400K polymorphisms in the ABCG8 gene and GSD in an Indian population, and the effects of these polymorphisms on cholesterol levels in sera and bile. 20594224 2010
Entrez Id: 686
Gene Symbol: BTD
BTD
0.020 Biomarker disease BEFREE When viewed from a global perspective, there are some lines of biotin biology that could indicate a relationship between BTD´s behavior and GSDs. 20532819 2010
Entrez Id: 1493
Gene Symbol: CTLA4
CTLA4
0.010 GeneticVariation disease BEFREE Our data suggest that CTLA4-318 C/T, +49 A/G, and CT60 A/G SNPs do not confer increased susceptibility to symptomatic GSD. 21277929 2011
Entrez Id: 53841
Gene Symbol: CDHR5
CDHR5
0.010 GeneticVariation disease BEFREE We conducted a case-control study to investigate the relationship between the mucin-like protocadherin (MUPCDH) gene polymorphisms and GSD. 21839066 2011
Entrez Id: 348120
Gene Symbol: LINC01193
LINC01193
0.010 GeneticVariation disease BEFREE Our data suggest that CTLA4-318 C/T, +49 A/G, and CT60 A/G SNPs do not confer increased susceptibility to symptomatic GSD. 21277929 2011
Entrez Id: 25801
Gene Symbol: GCA
GCA
0.010 Biomarker disease BEFREE The haplotype analysis of the three polymorphic SNPs showed GCA was significant for GSD (adjusted p=0.001) with an odds ratio (OR) of 1.41 when compared to other haplotypes. 21839066 2011
Entrez Id: 64240
Gene Symbol: ABCG5
ABCG5
0.010 GeneticVariation disease BEFREE ABCG5/8 variants did not fully explain the sterol metabolic trait of GSD in any of the cohorts. 22213168 2012
Entrez Id: 6927
Gene Symbol: HNF1A
HNF1A
0.010 AlteredExpression disease BEFREE In contrast, no HNF1A inactivation was observed, showing a different molecular subtype distribution in GSD-associated HCA from that observed in sporadic HCA (p = 0.0008). 23046672 2013
Entrez Id: 3572
Gene Symbol: IL6ST
IL6ST
0.010 GeneticVariation disease BEFREE GSD adenomas were classified as IHCA (52%) mutated for IL6ST or GNAS, bHCA (28%) or UHCA (20%). 23046672 2013
Entrez Id: 2778
Gene Symbol: GNAS
GNAS
0.010 GeneticVariation disease BEFREE GSD adenomas were classified as IHCA (52%) mutated for IL6ST or GNAS, bHCA (28%) or UHCA (20%). 23046672 2013
Entrez Id: 8972
Gene Symbol: MGAM
MGAM
0.020 GeneticVariation disease BEFREE Pompe disease is an autosomal recessive lysosomal glycogen storage disorder (GSD) caused by acid α-glucosidase (GAA) deficiency. 25026126 2014
Entrez Id: 6476
Gene Symbol: SI
SI
0.020 GeneticVariation disease BEFREE Pompe disease is an autosomal recessive lysosomal glycogen storage disorder (GSD) caused by acid α-glucosidase (GAA) deficiency. 25026126 2014
Entrez Id: 150
Gene Symbol: ADRA2A
ADRA2A
0.010 GeneticVariation disease BEFREE Since GSD may function as GBC precursor, the present study aimed to investigate the association of common functional genetic variants of ADRA2A C-1291G, ADRβ3 T190C or Trp64Arg, and ADRβ1 C1165G or Arg389Gly with GBC and GSD susceptibility. 24556804 2014
Entrez Id: 2538
Gene Symbol: G6PC
G6PC
0.100 Biomarker disease BEFREE Although liver biopsy revealed moderate fibrosis with a suggested diagnosis of glycogen storage disease (GSD), no mutations were identified either by single gene approach for GSD (G6PC and GAA) or by next generation sequencing panels for GSD (including 21 genes). 25681648 2015
Entrez Id: 5256
Gene Symbol: PHKA2
PHKA2
0.030 GeneticVariation disease BEFREE The aim of this study was to evaluate the PHKA2 mutation spectrum in Korean patients with GSD type IX. 27103379 2016
Entrez Id: 54797
Gene Symbol: MED18
MED18
0.010 GeneticVariation disease BEFREE These results show that next-generation sequencing, in combination with the detection of biochemical and clinical hallmarks, provides an accurate, high-throughput means of making genetic diagnoses of GSD and related diseases.Genet Med 18 10, 1037-1043. 26913919 2016
Entrez Id: 2169
Gene Symbol: FABP2
FABP2
0.010 GeneticVariation disease BEFREE High triglyceride levels were associated with patients that were FABP2 Thr54 allele carriers (p < 0.05) but lacked association with GSD. 26019038 2016
Entrez Id: 886
Gene Symbol: CCKAR
CCKAR
0.010 GeneticVariation disease BEFREE Expression of CCKAR protein was found to be significantly lower (p < 0.0001) in A1/A1 genotype as compared with other genotypes for GSD patients. 27287528 2016
Entrez Id: 5256
Gene Symbol: PHKA2
PHKA2
0.030 GeneticVariation disease BEFREE Here we first summarized the clinical data and analyzed the PHKA2 gene of 17 Chinese male patients suspected of having GSD type IXa. 28627441 2017
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.010 GeneticVariation disease BEFREE Glycogen storage disease (GSD) type IX and growth hormone (GH) deficiency cause ketotic hypoglycemia via different mechanisms and are not known to be associated. 28085675 2017
Entrez Id: 2992
Gene Symbol: GYG1
GYG1
0.010 GeneticVariation disease BEFREE Glycogen storage disease (GSD) type XV is a rare disease caused by mutations in the GYG1 gene that codes for the core molecule of muscle glycogen, glycogenin 1. 28453664 2017
Entrez Id: 2998
Gene Symbol: GYS2
GYS2
0.010 AlteredExpression disease BEFREE Our results support therapeutic silencing of GYS2 expression to prevent glycogen and lipid accumulation, which mediate initial signals that subsequently trigger cascades of long-term liver injury in GSDs. 29784585 2018